Report : North America E. coli Testing Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology (Monoclonal Antibodies, Differential Light Scattering, Molecular Diagnostics, Immunoassays, Chromatography, Flow Cytometry, Gel Microdroplets, and Diagnostic Imaging); End User (Commercial or Private Labs, Physician Offices, Hospitals, Public Health Labs, and Academic Research Institutes), and Country

Monoclonal Antibodies Segment Held Largest Share of E. coli Testing Market in 2019


According to our new market research study on “North AmericaE. coliTesting Marketto 2027 – Regional Analysis and Forecast – by Technology,and End-User”the market is expected to reach US$ 1,165.0 Mn by 2027 from US$ 680.9 Mn in 2019; it is estimated to grow at a CAGR of 7.1% from 2020 to 2027. The report provides trends prevailing in the North AmericaE. coliTestingmarket and the factors driving the market growth along with those hindering it.


Based on technology, the monoclonal antibodies segment accounted for the largest share of the E. coli testing market in 2019. However, the immunoassays segment is estimated to grow at the highest CAGR during the forecast period. Monoclonal antibodies offer advantages such as low cross-reactivity, high specificity, and excellent lot-to-lot stability, which are likely to contribute to the dominancy of the segment during the forecast period. Whereas, the rising adoption of immunotherapy for E. coli testing and increased reagents offering by companies are likely to serve wider growth opportunities during forecast period.


The growth of the North AmericaE. colitesting marketis mainly attributed to an increase inE. coli testing, growing product innovation, and rising research activities. However,testing challengesis the major factor hindering the market growth in North America.


A few of the leading companies operating in the North AmericaE. colitestingmarket include Bio-Rad Laboratories, Inc, Pro-Lab Diagnostics, Inc., Abbott (Alere Inc.), IDEXX Laboratories, Inc., Meridian Bioscience, Inc., BD, Thermo Fisher Scientific, Inc.,NEOGEN Corporation, and Hologic, Inc.

North America E. coli Testing Market, By Country, 2019 (%)

North America E. coli Testing Market, By Country, 2019 (%)

The report segments North America E. coli Testing market as follows:


North America E. coli Testing Market– ByTechnology

  • Monoclonal Antibodies
  • Differential Light Scattering
  • Molecular Diagnostics
  • Immunoassays
  • Chromatography
  • Flow Cytometry
  • Gel Microdroplets
  • Diagnostic Imaging


North America E. coli Testing Market – By End-User

  • Commercial or Private Labs
  • Physician Offices
  • Hospitals
  • Public Health Labs
  • Academic Research Institutes


North AmericaE. Coli Testing Market– By Country

  • North America
    • US
    • Canada
    • Mexico

Download Free PDF Brochure